1-{4-[2-(5-Ethoxymethyl-2-Methyl-Phenylamino)-Oxazol-5-Yl]-Phenyl}-Imidazolidin-2-One — Drug Intelligence | 1 EU Trials

Filter these 1 trials by condition, phase, country and more.

1 Registered trials

0 Recruiting

0 Completed trials

1 Sponsors

4 Countries

Phase I (FiH)

Phase I (FiH): 1

Oversight events:

4 temporary halts 2 corrective measures across 1 trial

Sponsors using this IMP

1 total

Showing 1–1 of 1 trials